Ellen Copson

COVID-19 prevalence and mortality in patients with cancer and the effect of primary tumour subtype and patient demographics: a prospective cohort study

Lennard Y. W. Lee, Jean‐Baptiste Cazier, Thomas Starkey et al. · The Lancet Oncology · 2020 · 600 citations · Full text

Medicine, Oncology, Cancer Epidemiology +16

Germline BRCA mutation and outcome in young-onset breast cancer (POSH): a prospective cohort study

Ellen Copson, Tom Maishman, William Tapper et al. · The Lancet Oncology · 2018 · 495 citations · Full text

Medicine, Genetics, Oncology +7

Overall survival in the OlympiA phase III trial of adjuvant olaparib in patients with germline pathogenic variants in BRCA1/2 and high-risk, early breast cancer

Charles E. Geyer, Judy E. Garber, Richard D. Gelber et al. · Annals of Oncology · 2022 · 447 citations · Full text

Medicine, Oncology, Pharmacotherapy +17

Prospective Observational Study of Breast Cancer Treatment Outcomes for UK Women Aged 18–40 Years at Diagnosis: The POSH Study

Ellen Copson, Bryony Eccles, Tom Maishman et al. · JNCI Journal of the National Cancer Institute · 2013 · 214 citations · Full text

Medicine, Geriatric Medicine, Oncology +15

Prediction of single‐nucleotide substitutions that result in exon skipping: identification of a splicing silencer in<i>BRCA1</i>exon 6

Michela Raponi, Jana Královičová, Ellen Copson et al. · Human Mutation · 2011 · 138 citations · Full text

Life Sciences, Genetics, Molecular Genetics +15